Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Dombi

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Neuro-Oncology Advances|October 4, 2021
Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1Caitlin Tydings, Pavel Yarmolenko, Miriam Bornhorst, et al.
Neuro-Oncology Advances|December 31, 2025
Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysisJohannes Salamon, Brigitte C Widemann, Andrea M Gross, et al.
Ophthalmology|November 8, 2016
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for CareRobert A Avery, James A Katowitz, Michael J Fisher, et al.
The Journal of Pediatrics|May 27, 2023
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1Chelsea Kotch, Eva Dombi, Amish C Shah, et al.
Orphanet Journal of Rare Diseases|October 6, 2012
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1Rosa Nguyen, Eva Dombi, Brigitte C Widemann, et al.
Neuro-Oncology|June 19, 2008
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1Victor-F Mautner, Florence A Asuagbor, Eva Dombi, et al.
The Journal of Pediatrics|December 11, 2013
Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type IUrania Dagalakis, Maya Lodish, Eva Dombi, et al.
Cells|May 13, 2026
Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic TargetLalitha Gopalan, Youjin Na, Liang Hu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2024
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath TumorsAngela C Hirbe, Carina A Dehner, Eva Dombi, et al.
Pediatric Blood & Cancer|May 31, 2012
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)Holly Meany, Eva Dombi, James Reynolds, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Neuro-Oncology Advances|October 4, 2021
Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1Caitlin Tydings, Pavel Yarmolenko, Miriam Bornhorst, et al.
Neuro-Oncology Advances|December 31, 2025
Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysisJohannes Salamon, Brigitte C Widemann, Andrea M Gross, et al.
Ophthalmology|November 8, 2016
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for CareRobert A Avery, James A Katowitz, Michael J Fisher, et al.
The Journal of Pediatrics|May 27, 2023
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1Chelsea Kotch, Eva Dombi, Amish C Shah, et al.
Orphanet Journal of Rare Diseases|October 6, 2012
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1Rosa Nguyen, Eva Dombi, Brigitte C Widemann, et al.
Neuro-Oncology|June 19, 2008
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1Victor-F Mautner, Florence A Asuagbor, Eva Dombi, et al.
The Journal of Pediatrics|December 11, 2013
Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type IUrania Dagalakis, Maya Lodish, Eva Dombi, et al.
Cells|May 13, 2026
Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic TargetLalitha Gopalan, Youjin Na, Liang Hu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2024
Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath TumorsAngela C Hirbe, Carina A Dehner, Eva Dombi, et al.
Pediatric Blood & Cancer|May 31, 2012
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)Holly Meany, Eva Dombi, James Reynolds, et al.
Pageof 10